Medicalgorithmics is supporting its Canadian partner in its development. An additional order worth USD 0.5 million.
Medicalgorithmics, a Warsaw Stock Exchange-listed developer of an innovative platform and AI algorithms for ECG analysis, is set to fulfil a further order for its long-standing Canadian client, which specialises in providing home-based Holter ECG monitoring services. The total value of the additional order is USD 0.5 million and is linked to the partner’s announced dynamic expansion in the Canadian market following its acquisition by a major healthcare player listed on the New York Stock Exchange. In December, the partner signed a new agreement with Medicalgorithmics for the supply of innovative software and devices worth at least USD 5.9 million. As a result of the additional order, the total minimum value of the partnership rises to USD 6.4 million.